Excellence in Medical Technology
Medyria is a Swiss medtech startup that engineers technologies for endovascular catheter navigation and sensing. Our goal is to make catheter based procedures FASTER, SAFER and MORE EFFECTIVE. Medyria’s core technology is a sensor-based system, called Flowcath, to measure blood flow and a revolutionary technology for processing flow data and tracking catheters called Trackcath. The combination of these two technologies creates a set of tools that will redefine how physicians navigate and track catheters during minimally invasive surgical procedures. The technology in its first application provides contrast-dye-free precise catheter guidance for stent placement.
Successfully concluded first set of animal trials. Medyria successfully concluded the first set of three animal trials. The Trackcath-CPS was tested in a pre-clinical environment by expert users including vascular and cardiac surgeons. The system showed excellent performances in pin-pointing anatomical landmarks used as reference for the positioning of endovascular grafts.
Medyria gets the CTI Label. The Start-up Label is a seal of quality, a certificate of achievement, and a sign of credibility and readiness for sustainable growth.
Medyria closes series A financial round for 2.2 MCHF with a group of private investors [press release].
Tel: +41 (0) 52 214 82 82+41 (0) 52 214 82 82